|Funding||Clatterbridge Charitable Funds|
Dose-painting radiotherapy for prostate cancer increases the radiation dose only to areas in the prostate containing tumour. Local control probability increases while toxicity is reduced or constant. Moreover, a hypofractionated shorter treatment schedule should improve tumour control. In this pilot study, we test the toxicity of dose-painting radiotherapy used in combination with a 4 week hypofractionated schedule rather than a standard 8 week schedule.